Thermo Fisher Scientific Inc. unit Thermo Fisher (CN) Luxembourg Sàrl extended the offering period of its tender offer to acquire all of the outstanding ordinary shares of Patheon NV.
The offer is being extended to coordinate with the timing of the two remaining regulatory approvals in the European Union and Brazil.
As of Aug. 4, 111,655,983 Patheon ordinary shares, representing about its 77% of ordinary shares, had been validly tendered and not properly withdrawn.
The offer will expire Aug. 28, unless extended or terminated earlier. The company now expects to complete the deal around the end of the third quarter.
D.F. King & Co. is acting as information agent for the offer. American Stock Transfer & Trust Co. LLC is the depositary for the tender offer.